Neuroendocrine Tumors: Etiology, Diagnosis, and Therapy—2nd Edition
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: 25 September 2024 | Viewed by 2010
Special Issue Editor
Interests: celiac disease; autoimmune atrophic gastritis; diet; nutrition; micronutrient deficiency
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are thrilled to announce the upcoming release of our second volume of this Special Issue series, titled "Neuroendocrine Tumors: Etiology, Diagnosis, and Therapy—Volume II”. We also invite you to visit our website to access the first volume of our Special Issue, available at the following link: https://www.mdpi.com/journal/jcm/special_issues/neuro_endocrine_tumor.
Neuroendocrine neoplasms (NENs) are rare and heterogeneous tumors whose incidence has increased in recent years due to better disease knowledge and improvements in diagnostic tools, particularly endoscopy and nuclear medicine. They frequently arise from the gastro-enteropancreatic (GEP) tract, representing approximately 2% of all malignant tumors of the GEP system.
Given their rarity and clinical and biological heterogeneity, there is an urgent need for standardized guidelines for the proper management of these neoplasms, which should always be referred to tertiary referral centers. Novel research strategies are needed to better define diagnostic and therapeutic algorithms, particularly for some specific subgroups of poorly known tumors, including duodenal NENs and functioning tumors. The cooperation between referral centers and the creation of international disease registries should be encouraged to better understand the biology and natural history of these neoplasms and consequently improve their management.
The focus of this Special Issue is to consider the following research aspects of NENs: (1) epidemiology and risk factors to define specific subgroups of patients characterized by dismal prognosis; (2) genomic characterization; and (3) innovations in multidisciplinary management in both diagnosis and treatment, including surgery (resection and liver transplant), loco-regional treatments, and medical therapy in adjuvant, neoadjuvant, and metastatic settings.
We extend our sincere gratitude for your continued support of our Special Issue series and eagerly anticipate your contributions to future volumes, contributing to the ongoing progress in neuroendocrine neoplasms research.
Dr. Roberta Elisa Rossi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroendocrine tumors
- carcinoid syndrome
- gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
- somatostatin receptor imaging
- peptide receptor radionuclide therapy (PRRT)
- neuroendocrine differentiation
- multiple endocrine neoplasia (MEN)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.